[PDF] Top 20 Formulation and development of oral sustained release systems for selected drug candidates.
Has 10000 "Formulation and development of oral sustained release systems for selected drug candidates." found on our website. Below are the top 20 most common "Formulation and development of oral sustained release systems for selected drug candidates.".
Formulation and development of oral sustained release systems for selected drug candidates.
... newer drug delivery systems have been designed and evaluated in order to overcome the limitations of conventional drug ...The oral controlled/sustained release dosage forms are ... See full document
225
Development and validation of In Vitro – In Vivo Correlations for the developed modified release formulations of selected drug candidates.
... for formulation series are useful in drug development, but the current models are limited by their inability to include data variability in the ...for formulation optimization and for ... See full document
236
Formulation Development and Evaluation of Sustained Release Tablets of Aceclofenac
... Zero-order release constitutes drug release from the dosage form that is independent of the amount of drug in the delivery system ...constant release rate). Sustained ... See full document
128
Development of sustained release hydrophobic emulgel for oral care
... emulgel formulation can be formulated with the composition of Doxycycline hyclate, Eugenol, Isopropyl Myristate, Mineral Oil, Butylatedhydroxytoluene, Sorbitan Stearate, Polysorbate 20, Emulsifying wax, Cetyl ... See full document
8
FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE MATRIX TABLETS OF METFORMIN HYDROCHLORIDE
... extended-release drug therapy as tablets offer the lowest cost approach to sustained and controlled release solid dosage ...the drug or active ingredient is homogeneously dispersed ... See full document
11
Formulation Development and Evaluation of Valsartan Sodium Sustained Release Tablets
... and drug release were ...The formulation F-7 was showed good drug release and selected as an optimized formulation and it was concluded that superdisintegrant ... See full document
91
Formulation Development of Metformin Hydrochloride Sustained Release Tablets
... evaluate drug release parameters as per various release kinetic ...the development of Metformin hydrochloride release dosage form is to increase bioavailability; reduce risk of ... See full document
137
IN VITRO EVALUATION OF EFFECT OF HYDROALCOHOLIC MEDIA ON DRUG RELEASE FROM SUSTAINED RELEASE FORMULATION
... recent development; worldwide consumption of alcohol has shot up in the past decade as a part of lavish and Gen next lifestyle ...were selected as representatives of highly prescribed and overused ...study ... See full document
8
FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE TABLETS OF LORNOXICAM
... anti-inflammatory drug, Lornoxicam has short half-life (3-5 hr.), makes the development of sustained-release (SR) forms extremely advantageous, lornoxicam is weak acid having pKa ...action. ... See full document
8
DESIGN AND DEVELOPMENT OF ORAL SUSTAINED RELEASE MATRIX TABLETS OF DIDANOSINE
... for drug Didanosine, formulation with xanthan gum, formulation with guar gum and formulation with karaya gum were recorded in a Fourier transform infrared (FTIR) spectrophotometer (FTIR 1615, ... See full document
7
FORMULATION & DEVELOPMENT OF ACECLOFENAC AND OMEPRAZOLE SUSTAINED RELEASE MICROSPHERES
... any drug delivery system is to provide a therapeutic amount of drug to the proper site in the body to achieve promptly and then maintain the desired drug ...of drug delivery has historically ... See full document
11
Formulation Development and Evaluation of Bilayer Tablets of Lisinopril for Immediate Release and Glipizide for Sustained Release
... immediate release component using sodium starch glycolate and cross carmillose sodium as super disintegrates and Metformin hydrochloride (HCl) for sustained release by using hydroxyl propyl methyl ... See full document
146
DEVELOPMENT AND IN VITRO CHARACTERISATION OF ORAL SUSTAINED RELEASE MATRIX TABLETS OF GEMIGLIPTIN
... the development of sustained release matrix tablets of ...an oral anti-hyperglycemic agent designed for the management of non insulin dependent diabetes mellitus ...which drug ... See full document
11
“Sustained Release Oral Drug Delivery System: A Concise Review” by Sandhya Mishra, India.
... Traditional drug delivery system has been characterized by immediate release and repeated dosing of the drug which might lead to the risk of dose fluctuation, this arises the need of a ... See full document
11
Formulation development and evaluation of metoprolol succinate sustained release and hydrochlorothiazide immediate release bilayer tablet
... as drug carrier[1]. The oral route of administration has been used for both conventional and novel drug delivery ...the development of new techniques for drug delivery ...of drug ... See full document
9
FORMULATION DEVELOPMENT AND EVALUATION OF METOPROLOL SUCCINATE SUSTAINED RELEASE AND HYDROCHLOROTHIAZIDE IMMEDIATE RELEASE BILAYER TABLET
... extended release dosage form (e.g.) sustained drug delivery system can be a major advance in this direction 3 ...but oral administration is adopted wherever ...non- oral products and ... See full document
8
Development of Mucoadhesive Sustained Release Matrix Tablets of Methimazole for Oral Delivery
... develop sustained release matrix tablets containing ...vitro drug release and stability ...the formulation batch MT 6 has a mucoadhesion force about ...that drug release ... See full document
10
A COMPREHENSIVE REVIEW ON: SUSTAINED RELEASE MATRIX TYPE DRUG DELIVERY SYSTEMS
... an oral controlled release ...the release profile of ...uniform drug levels, reduce dose and side effects, and increase safety margin for high potency ...matrix systems are widely used ... See full document
14
Floating multiparticulate oral sustained release drug delivery system
... delivery systems which enhance desirable therapeutic objectives while minimizing side ...multiparticulate drug delivery systems are especially suitable for achieving sustained or delayed ... See full document
12
Biochronomer™ technology and the development of APF530, a sustained release formulation of granisetron
... poly(orthoester)-based formulation that delivers – by single subcutaneous (SC) injection – therapeutic granisetron concentrations over 5 ...polymer systems are specifically designed for controlled, ... See full document
7
Related subjects